Urs Droese on the Swiss Market's Perfect Pair of Pharmaceuticals and Innovation
WHVP Chief Investment Officer Urs Droese joins Citywire's Swiss Equities in Focus to discuss what makes the Swiss market distinctive: the stability of pharmaceuticals, the role of innovation in protecting companies against a strong franc, and the opportunities in medical technology and infrastructure.